Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Infectious Diseases

• Publication date

  2002-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/340651PMID 12085316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytomegalovirus (CMV) DNA Load Is an Independent Predictor of CMV Disease and Survival in Advanced AIDS

  1999influential reference
• Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group

  1999cited by this paper
• Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy.

  1999cited by this paper
• Strategies for Cohort Sampling Under the Cox Proportional Hazards Model, Application to an AIDS Clinical Trial

  1999cited by this paper
• The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.

  1998cited by this paper
• A Randomized, Double-Blind Trial of Valaciclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection

  1998cited by this paper
• Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.

  1998cited by this paper
• Studies of viral co-factors for human immunodeficiency virus in vitro and in vivo.

  1998cited by this paper
• A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.

  1998cited by this paper
• Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV‐positive patients at high risk of CMV disease

  1997cited by this paper
• TAR and Sp1‐independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2

  1997cited by this paper
• Development of cytomegalovirus (CMV) disease may be predicted in HIV‐infected patients by CMV polymerase chain reaction and the antigenemia test

  1997cited by this paper
• Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS.

  1996cited by this paper
• Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group.

  1996cited by this paper
• Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival

  1996cited by this paper
• Human cytomegalovirus-mediated enhancement of human immunodeficiency virus type-1 production in monocyte-derived macrophages.

  1994cited by this paper
• Effects of high‐dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double‐blind, placebo‐controlled study

  1994cited by this paper
• Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. European-Australian Acyclovir Study Group.

  1994cited by this paper
• Involvement of cAMP and Protein Kinase C in Cytomegalovirus Enhancement of Human Immunodeficiency Virus Replication

  1993cited by this paper
• PROVISION OF PROGNOSTIC INFORMATION IN IMMUNOCOMPROMISED PATIENTS BY ROUTINE APPLICATION OF THE POLYMERASE CHAIN REACTION FOR CYTOMEGALOVIRUS

  1993cited by this paper
• The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.

  1993cited by this paper
• Cytomegalovirus Ventriculoencephalitis in AIDS: A Syndrome with Distinct Clinical and Pathologic Features

  1993cited by this paper
• The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS‐related complex: a double‐blind, randomized trial

  1993cited by this paper
• Interactions between cytomegalovirus immediate‐early proteins and the long terminal repeat of human immunodeficiency virus

  1993cited by this paper
• Cytomegalovirus infection in patients with AIDS.

  1992cited by this paper
• Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

  1992cited by this paper
• Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus.

  1992cited by this paper
• Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection.

  1989cited by this paper
• Cytomegalovirus retinitis and acquired immunodeficiency syndrome.

  1989cited by this paper
• Asymptotic Distribution Theory and Efficiency Results for Case-Cohort Studies

  1988cited by this paper
• Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.

  1988cited by this paper
• Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment.

  1988cited by this paper
• Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature.

  1987cited by this paper

• Human cytomegalovirus infection, viraemia and retinitis among people living with HIV/AIDS in Kano, North-Western Nigeria

  2021influential citation
• Generalized case-cohort and inference for Cox’s model with parameter constraints

  2020cites this paper
• Fever of unknown origin: a clinical approach.

  2015cites this paper
• A class of weighted estimators for additive hazards model in case-cohort studies

  2014cites this paper
• A class of weighted estimators for additive hazards model in case-cohort studies

  2014cites this paper
• Varón de 50 años, VIH positivo, con trombopenia y rectorragias

  2014cites this paper
• Cytomegalovirus infection in patients with HIV-1. Diagnosis, disease, and death in coinfected patients in Norway and Tanzania.

  2013cites this paper
• Treatment and prevention of cytomegalovirus-associated diseases in HIV - 1 infection in the era of HAART

  2010cites this paper
• Prevalence, Risk Factors, and Impact on Outcome of Cytomegalovirus Replication in Serum of Cambodian HIV-Infected Patients (2004-2007)

  2009cites this paper
• Aymptomatic CMV viremia is associated with increased levels of serum amyloid A in patients with advanced HIV-infection.

  2008cites this paper
• AYMPTOMATICCMV VIREMIAISASSOCIATEDWITHINCREASEDLEVELS OFSERUMAMYLOIDA INPATIENTSWITHADVANCEDHIV-INFECTION

  2008cites this paper
• [Evaluation of Biosewoom Real-Q Cytomegalovirus Quantification kit for Cytomegalovirus viral load measure].

  2007influential citation
• CMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection – a retrospective autopsy based study

  2007cites this paper
• Fever of unknown origin in HIV/AIDS patients.

  2007cites this paper
• Evaluation of Biosewoom TM Real-Q Cytomegalovirus Quantification kit for Cytomegalovirus

  2007cites this paper
• Prevalence of human cytomegalovirus DNA in scleroderma skin tissue

  2006cites this paper
• Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART).

  2006cites this paper
• Viral and host gene expression during human cytomegalovirus infection.

  2005cites this paper
• Results of a cytomegalovirus (CMV)-specific CD8+/interferon- gamma+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in patients with AIDS with CMV retinitis.

  2004cites this paper
• Improving the Efficiency of Relative-Risk Estimation in Case-Cohort Studies

  2004cites this paper
• Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360).

  2003cites this paper
• Significance of cytomegalovirus infection in renal transplantation.

  2003cites this paper
• Fever of Unknown Origin in HIV / AIDS Patients Arnaud Hot , MDa ,

  year unknowncites this paper